Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Casellas

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Journal of Leukocyte Biology|March 25, 2000
A beneficial aspect of a CB1 cannabinoid receptor antagonist: SR141716A is a potent inhibitor of macrophage infection by the intracellular pathogen Brucella suisA Gross, A Terraza, J Marchant, et al.
Biochimica Et Biophysica Acta|July 31, 2001
Expression pattern of the type 1 sigma receptor in the brain and identity of critical anionic amino acid residues in the ligand-binding domain of the receptorP Seth, M E Ganapathy, S J Conway, et al.
FEBS Letters|December 16, 1996
Effect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: characterization of novel tachykinin receptor antagonistsJ M Derocq, M Ségui, C Blazy, et al.
Nature|March 12, 1981
Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cellsH E Blythman, P Casellas, O Gros, et al.
Journal of Neuroimmunology|July 1, 1994
Allosteric modulation of peripheral sigma binding sites by a new selective ligand: SR 31747R Paul, S Lavastre, D Floutard, et al.
British Journal of Cancer|June 23, 2000
Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factorsJ Simony-Lafontaine, M Esslimani, E Bribes, et al.
Cancer Research|May 1, 1986
Determination of sensitivity of fresh leukemia cells to immunotoxinsG Laurent, E Kuhlein, P Casellas, et al.
The Biochemical Journal|December 1, 1995
Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1M Bouaboula, C Poinot-Chazel, B Bourrié, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 24, 1998
Modulation of CB1 cannabinoid receptor functions after a long-term exposure to agonist or inverse agonist in the Chinese hamster ovary cell expression systemM Rinaldi-Carmona, A Le Duigou, D Oustric, et al.
Biochemical Pharmacology|February 11, 1994
Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on Swiss 3T3 cellsC Serradeil-Le Gal, B Bourrié, D Raufaste, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Journal of Leukocyte Biology|March 25, 2000
A beneficial aspect of a CB1 cannabinoid receptor antagonist: SR141716A is a potent inhibitor of macrophage infection by the intracellular pathogen Brucella suisA Gross, A Terraza, J Marchant, et al.
Biochimica Et Biophysica Acta|July 31, 2001
Expression pattern of the type 1 sigma receptor in the brain and identity of critical anionic amino acid residues in the ligand-binding domain of the receptorP Seth, M E Ganapathy, S J Conway, et al.
FEBS Letters|December 16, 1996
Effect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: characterization of novel tachykinin receptor antagonistsJ M Derocq, M Ségui, C Blazy, et al.
Nature|March 12, 1981
Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cellsH E Blythman, P Casellas, O Gros, et al.
Journal of Neuroimmunology|July 1, 1994
Allosteric modulation of peripheral sigma binding sites by a new selective ligand: SR 31747R Paul, S Lavastre, D Floutard, et al.
British Journal of Cancer|June 23, 2000
Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factorsJ Simony-Lafontaine, M Esslimani, E Bribes, et al.
Cancer Research|May 1, 1986
Determination of sensitivity of fresh leukemia cells to immunotoxinsG Laurent, E Kuhlein, P Casellas, et al.
The Biochemical Journal|December 1, 1995
Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1M Bouaboula, C Poinot-Chazel, B Bourrié, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 24, 1998
Modulation of CB1 cannabinoid receptor functions after a long-term exposure to agonist or inverse agonist in the Chinese hamster ovary cell expression systemM Rinaldi-Carmona, A Le Duigou, D Oustric, et al.
Biochemical Pharmacology|February 11, 1994
Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on Swiss 3T3 cellsC Serradeil-Le Gal, B Bourrié, D Raufaste, et al.
Pageof 10